KYMR Kymera Therapeutics, Inc. - Common Stock
$124,12
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 5, 2026
Rango 52S
$40–$130
93% of range
Calificación del Analista
BUY
30 analysts
Precio Objetivo
$131
+5% upside
P/E (TTM)
-33.6
ROE
-24.4%
Margen de Beneficio Neto
-794.0%
Acerca de Kymera Therapeutics, Inc. - Common Stock Descripción general de la empresa de Wikipedia
KYMR Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$124.12
Capitalización Bursátil
$10.09B
P/E (TTM)
-33.6
BPA (TTM)
$-3.69
Ingresos (TTM)
$39M
Rendimiento div.
—
ROE
-24.4%
Deuda/Capital
—
Rango 52S
$40 – $130
KYMR Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
$39M
2019-12-31
→
2025-12-31
BPA
$-3.69
2020-12-31
→
2025-12-31
Flujo de caja libre
$-234M
2020-12-31
→
2025-12-31
Márgenes
-794.0%
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
KYMR
Mediana de Pares
P/E (TTM)
-33.6
16.0
P/S (TTM) (P/V (TTM))
257.4
32.5
P/B (P/C)
6.4
3.9
Price / FCF (Precio / FCF)
-43.1
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
KYMR
Mediana de Pares
Operating Margin (Margen Operativo)
-891.1%
—
Net Profit Margin (Margen de Beneficio Neto)
-794.0%
-93.3%
ROA
-22.9%
-22.2%
ROE
-24.4%
-37.6%
ROIC
-22.1%
—
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
KYMR
Mediana de Pares
Current Ratio (Ratio corriente)
10.5
5.7
Quick Ratio (Ratio Rápido)
4.3
—
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
KYMR
Mediana de Pares
Revenue YoY (Ingresos interanuales)
-16.7%
—
Revenue CAGR 3Y (Ingresos CAGR 3A)
-5.7%
—
Revenue CAGR 5Y (Ingresos CAGR 5A)
2.9%
—
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
KYMR
Mediana de Pares
KYMR Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
30 analistas
- Compra fuerte 10 33,3%
- Compra 16 53,3%
- Mantener 4 13,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
22 analistas · 2026-08-16
Mediana
$133.00
Ahora
$124.12
Mín
$111.00
Máx
$155.00
Objetivo mediano
$133.00
+7,2%
Objetivo medio
$130.91
+5,5%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.00%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.62 | $-0.73 | 0.11% |
| 31 de marzo de 2026 | $-0.71 | $-0.90 | 0.19% |
| 31 de diciembre de 2025 | $-0.97 | $-0.81 | -0.16% |
| 30 de septiembre de 2025 | $-0.94 | $-0.82 | -0.12% |
| 30 de junio de 2025 | $-0.95 | $-0.83 | -0.12% |
| 31 de marzo de 2025 | $-0.82 | $-0.93 | 0.11% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| KYMR | $6.33B | -21.1 | -16.7% | -794.0% | -24.4% | — |
| CYTK | $7.81B | -9.7 | 376.6% | -891.6% | 152.7% | — |
| PRAX | $7.43B | -21.9 | 249.5% | — | -47.3% | — |
| SMMT | $13.56B | -12.1 | — | — | -235.1% | — |
| PTGX | $5.47B | -42.6 | -89.4% | -282.8% | -20.3% | — |
| APGE | $5.16B | -17.9 | — | — | — | — |
| KRYS | $7.20B | 36.0 | 33.9% | 52.6% | 18.1% | — |
| IONS | $12.92B | -33.2 | — | — | -68.1% | — |
| SYRE | $2.56B | 10.1 | -62.0% | — | -26.5% | — |
| IMVT | $5.07B | -9.0 | 229.2% | — | -73.7% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 15
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $39M | $47M | $79M | $47M | $73M | $34M | $3M | |
| Cost of Revenue | $39M | $47M | $79M | $47M | · | · | · | |
| R&D Expense | $317M | $240M | $189M | $164M | $137M | $62M | $37M | |
| SG&A Expense | $68M | $64M | $55M | $44M | $36M | $18M | $8M | |
| Operating Expenses | $389M | $309M | $244M | $208M | $173M | $80M | $45M | |
| Operating Income | $-349M | $-262M | $-166M | $-161M | $-101M | $-46M | $-42M | |
| Other Non-op | $38M | $38M | $19M | $6M | $313.0K | $711.0K | $959.0K | |
| Pretax Income | $-311M | · | · | · | · | · | · | |
| Income Tax | $0 | · | · | $0 | $0 | $0 | $0 | |
| Net Income | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | $-41M | |
| EPS (Basic) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| EPS (Diluted) | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 | $-3.15 | · | |
| Shares (Basic) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| Shares (Diluted) | 84,490,585 | 75,043,991 | 58,365,499 | 53,933,229 | 47,989,023 | 17,349,582 | · | |
| EBITDA | $-341M | $-254M | $-162M | $-158M | $-98M | $-45M | · |
Balance general 21
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $357M | $120M | $110M | $68M | $48M | $31M | $76M | |
| Receivables | $0 | $0 | $15M | $0 | · | · | · | |
| Prepaid Expense | $23M | $22M | $12M | $10M | $9M | $5M | $888.0K | |
| Current Assets | $871M | $510M | $405M | $419M | $451M | $302M | $93M | |
| PP&E (Net) | $43M | $50M | $48M | $13M | $12M | $11M | $4M | |
| PP&E (Gross) | $65M | $67M | $59M | $20M | $16M | $13M | $5M | |
| Accum. Depreciation | $22M | $16M | $10M | $7M | $4M | $2M | $1M | |
| Other Non-current Assets | $9M | $2M | $2M | $3M | $2M | $30.0K | $2M | |
| Total Assets | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Accounts Payable | $4M | $6M | $7M | $4M | $4M | $4M | $3M | |
| Accrued Liabilities | $42M | $35M | $34M | $28M | $23M | $10M | $5M | |
| Current Liabilities | $83M | $68M | $86M | $71M | $93M | $111M | $35M | |
| Capital Leases | $67M | $72M | $77M | $12M | $13M | $14M | $17M | |
| Other Non-current Liabilities | · | $0 | $0 | $248.0K | $66.0K | $100.0K | · | |
| Total Liabilities | $163M | $142M | $181M | $113M | $146M | $203M | $82M | |
| Common Stock | $8.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | · | |
| Retained Earnings | $-1.07B | $-755M | $-531M | $-384M | $-229M | $-129M | $-76M | |
| AOCI | $2M | $-1M | $-552.0K | $-5M | $-660.0K | $-128.0K | $6.0K | |
| Stockholders' Equity | $1.58B | $836M | $395M | $490M | $460M | $284M | $-74M | |
| Liabilities + Equity | $1.74B | $978M | $576M | $603M | $606M | $487M | $117M | |
| Shares Outstanding | 81,323,532 | 64,890,193 | 55,585,305 | 55,039,380 | 51,536,181 | 44,482,186 | 1,929,516 |
Flujo de Efectivo 9
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $7M | $4M | $3M | $2M | $2M | $825.0K | |
| Stock-based Comp | $60M | $55M | $43M | $35M | $25M | $5M | $1M | |
| Other Non-cash | $10M | $-33M | $-3M | $-37M | $-56M | $127M | · | |
| Operating Cash Flow | $-233M | $-195M | $-103M | $-153M | $-129M | $88M | $18M | |
| CapEx | $1M | $13M | $34M | $3M | $2M | $9M | $532.0K | |
| Investing Cash Flow | $-521M | $-404M | $140M | $21M | $-100M | $-423M | $-16M | |
| Financing Cash Flow | $991M | $609M | $4M | $153M | $250M | $289M | $35M | |
| Net Change in Cash | $237M | $10M | $41M | $20M | $21M | $-45M | $36M | |
| Free Cash Flow | $-234M | $-207M | $-137M | $-156M | $-131M | $79M | · |
Rentabilidad 7
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% | -136.1% | · | |
| Net Margin | -794.0% | -475.6% | -187.0% | -330.6% | -137.6% | -134.0% | · | |
| Pretax Margin | -794.0% | · | · | · | · | · | · | |
| EBITDA Margin | -869.9% | -540.2% | -206.1% | -338.0% | -134.7% | -130.9% | · | |
| ROA | -22.9% | -28.8% | -24.9% | -25.6% | -18.3% | -15.1% | · | |
| ROE | -24.4% | -25.9% | -37.2% | -30.9% | -21.3% | -15.8% | · | |
| ROIC | -22.1% | · | · | · | · | · | · |
Liquidez y Solvencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 | 2.7 | · | |
| Quick Ratio | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 | 0.3 | · |
Eficiencia 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | · | |
| Receivables Turnover | · | 6.3 | 10.5 | · | · | · | · |
Tasas de Crecimiento 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -16.7% | -40.1% | 67.8% | -35.7% | 114.0% | · | · | |
| Revenue CAGR 3Y | -5.7% | -13.5% | 32.2% | · | · | · | · | |
| Revenue CAGR 5Y | 2.9% | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $39M | $47M | $79M | $47M | $73M | $34M | · | |
| Net Income TTM | $-311M | $-224M | $-147M | $-155M | $-100M | $-46M | · | |
| Market Cap | $6.33B | $2.61B | · | $1.37B | $3.27B | $2.76B | · | |
| P/E | -21.1 | -13.5 | -10.1 | -8.7 | -30.4 | -19.7 | · | |
| P/S | 161.4 | 55.5 | · | 29.3 | 44.9 | 81.0 | · | |
| P/B | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Tangible Book | 4.0 | 3.1 | · | 2.8 | 7.1 | 9.7 | · | |
| P / Cash Flow | -27.2 | -13.4 | · | -9.0 | -25.4 | 31.3 | · | |
| P / FCF | -27.0 | -12.6 | · | -8.8 | -25.1 | 34.9 | · | |
| Earnings Yield | -4.7% | -7.4% | -9.9% | -11.5% | -3.3% | -5.1% | · |
Estado de resultados 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | $48M | $5M | $17M | $9M | $16M | $10M | |
| Cost of Revenue | $65M | $34M | $3M | $3M | $11M | $22M | $7M | $4M | $26M | $10M | · | · | · | · | · | · | |
| R&D Expense | $119M | $98M | $84M | $74M | $78M | $80M | $72M | $60M | $59M | $49M | $53M | $48M | $46M | $42M | $43M | $44M | |
| SG&A Expense | $21M | $20M | $17M | $17M | $18M | $16M | $16M | $15M | $17M | $14M | $14M | $14M | $14M | $13M | $12M | $11M | |
| Operating Expenses | $141M | $119M | $101M | $95M | $96M | $97M | $88M | $76M | $77M | $68M | $67M | $62M | $60M | $55M | $55M | $54M | |
| Operating Income | $-76M | $-84M | $-98M | $-93M | $-85M | $-74M | $-81M | $-72M | $-51M | $-58M | $-19M | $-58M | $-43M | $-45M | $-39M | $-45M | |
| Other Non-op | $14M | $15M | $11M | $10M | $8M | $9M | $10M | $10M | $9M | $9M | $5M | $5M | $5M | $4M | $4M | $2M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $100.0K | $100.0K | $0 | · | $0 | |
| Net Income | $-61M | $-69M | $-87M | $-82M | $-77M | $-66M | $-71M | $-62M | $-42M | $-49M | $-14M | $-53M | $-39M | $-41M | $-35M | $-43M | |
| EPS (Basic) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| EPS (Diluted) | $-0.62 | $-0.71 | $-0.98 | $-0.94 | $-0.95 | $-0.82 | $-0.89 | $-0.82 | $-0.58 | $-0.69 | $-0.25 | $-0.90 | $-0.67 | $-0.70 | $-0.59 | $-0.79 | |
| Shares (Basic) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| Shares (Diluted) | 98,177,158 | 97,534,269 | -163,405,637 | 87,300,286 | 80,449,405 | 80,146,531 | -144,911,702 | 76,125,975 | 73,059,398 | 70,770,320 | -116,570,361 | 58,421,859 | 58,326,963 | 58,187,038 | -104,025,850 | 54,535,514 | |
| EBITDA | $-76M | $-82M | · | $-93M | $-85M | $-72M | · | $-72M | $-51M | $-56M | · | $-58M | $-43M | $-44M | · | $-45M |
Balance general 21
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $124M | $144M | $357M | $113M | $336M | $90M | $120M | $111M | $68M | $94M | $110M | $81M | $52M | $50M | $68M | $156M | |
| Receivables | $20M | · | · | · | $40M | · | · | $0 | $0 | $0 | · | · | · | · | · | · | |
| Prepaid Expense | $26M | $27M | $23M | $23M | $23M | $18M | $22M | $17M | $14M | $15M | · | $14M | $14M | $11M | · | $9M | |
| Current Assets | $737M | $677M | $871M | $528M | $728M | $501M | $510M | $569M | $525M | $537M | · | $376M | $385M | $412M | · | $494M | |
| PP&E (Net) | $40M | $42M | $43M | $45M | $49M | $49M | $50M | $51M | $52M | $49M | · | $36M | $27M | $17M | · | $13M | |
| PP&E (Gross) | $66M | $66M | $65M | $67M | $69M | $67M | $67M | $65M | $64M | $60M | · | $46M | $36M | $25M | · | $19M | |
| Accum. Depreciation | $26M | $24M | $22M | $22M | $20M | $18M | $16M | $14M | $12M | $11M | · | $10M | $9M | $8M | · | $6M | |
| Other Non-current Assets | $7M | $8M | $9M | $7M | $5M | $3M | $2M | $0 | $2M | $2M | · | $3M | $3M | $3M | · | $3M | |
| Total Assets | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Accounts Payable | $9M | $13M | $4M | $6M | $6M | $10M | $6M | $6M | $7M | $7M | · | $5M | $4M | $6M | · | $6M | |
| Accrued Liabilities | $48M | $35M | $42M | $29M | $28M | $23M | $35M | $27M | $24M | $16M | · | $26M | $22M | $19M | · | $25M | |
| Current Liabilities | $71M | $63M | $83M | $72M | $88M | $59M | $68M | $67M | $62M | $56M | · | $63M | $55M | $62M | · | $91M | |
| Capital Leases | $64M | $66M | $67M | $68M | $70M | $71M | $72M | $74M | $75M | $76M | · | $77M | $71M | $64M | · | $12M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | $8.0K | $230.0K | $237.0K | · | $256.0K | |
| Total Liabilities | $136M | $129M | $163M | $156M | $160M | $132M | $142M | $142M | $141M | $157M | · | $157M | $147M | $152M | · | $126M | |
| Common Stock | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $7.0K | $7.0K | $7.0K | $6.0K | $6.0K | · | $6.0K | $6.0K | $6.0K | · | $6.0K | |
| Retained Earnings | $-1.20B | $-1.14B | $-1.07B | $-979M | $-897M | $-820M | $-755M | $-684M | $-621M | $-579M | · | $-516M | $-464M | $-425M | · | $-349M | |
| AOCI | $-7M | $-4M | $2M | $2M | $279.0K | $-58.0K | $-1M | $2M | $-2M | $-2M | · | $-2M | $-4M | $-3M | · | $-6M | |
| Stockholders' Equity | $1.51B | $1.54B | $1.58B | $946M | $971M | $786M | $836M | $893M | $685M | $711M | $395M | $396M | $435M | $462M | $490M | $513M | |
| Liabilities + Equity | $1.65B | $1.67B | $1.74B | $1.10B | $1.13B | $918M | $978M | $1.03B | $826M | $868M | · | $552M | $582M | $614M | · | $638M | |
| Shares Outstanding | 82,788,253 | 82,182,101 | 81,323,532 | 71,741,174 | 70,557,442 | 65,112,714 | 64,890,193 | 64,748,226 | 61,572,383 | 61,353,146 | · | 55,450,239 | 55,390,259 | 55,276,226 | · | 54,751,429 |
Flujo de Efectivo 9
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $891.0K | $895.0K | $900.0K | $879.0K | $818.0K | $767.0K | |
| Stock-based Comp | $19M | $16M | $14M | $16M | $15M | $14M | $14M | $15M | $14M | $12M | $11M | $12M | $11M | $9M | $9M | $9M | |
| Other Non-cash | · | $-38M | · | · | · | $-30M | · | · | · | $-4M | · | · | · | $-13M | · | · | |
| Operating Cash Flow | $-54M | $-89M | $-67M | $-27M | $-60M | $-79M | $-62M | $-50M | $-43M | $-40M | $8M | $-32M | $-35M | $-44M | $-40M | $-34M | |
| CapEx | $473.0K | $434.0K | $106.0K | $181.0K | $695.0K | $467.0K | $936.0K | $-189.0K | $5M | $7M | $12M | $8M | $11M | $4M | $373.0K | $1M | |
| Investing Cash Flow | $20M | $-143M | $-394M | $-235M | $60M | $49M | $69M | $-158M | $16M | $-331M | $19M | $61M | $36M | $25M | $-50M | $-37M | |
| Financing Cash Flow | $14M | $19M | $705M | $40M | $246M | $258.0K | $3M | $251M | $1M | $354M | $2M | $-206.0K | $1M | $1M | $2M | $150M | |
| Net Change in Cash | $-20M | $-213M | $244M | $-223M | $246M | $-30M | $10M | $43M | $-26M | $-16M | $29M | $29M | $2M | $-18M | $-87M | $79M | |
| Free Cash Flow | · | $-89M | · | · | · | $-80M | · | · | · | $-47M | · | · | · | $-48M | · | · |
Rentabilidad 5
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -116.3% | -244.9% | · | -3347.4% | -736.8% | -336.8% | · | -1927.9% | -198.5% | -562.2% | · | -1216.4% | -262.7% | -478.8% | · | -469.9% | |
| Net Margin | -94.2% | -201.5% | · | -2973.0% | -667.6% | -296.8% | · | -1670.3% | -164.0% | -472.0% | · | -1118.2% | -235.0% | -432.4% | · | -450.2% | |
| EBITDA Margin | -116.3% | -239.0% | · | -3347.4% | -736.8% | -327.5% | · | -1927.9% | -198.5% | -548.0% | · | -1216.4% | -262.7% | -469.5% | · | -469.9% | |
| ROA | -4.4% | -5.3% | · | -7.7% | -7.8% | -7.3% | · | -7.9% | -6.0% | -6.6% | · | -8.9% | -7.0% | -7.0% | · | -6.7% | |
| ROE | -4.9% | -5.9% | · | -8.9% | -9.2% | -8.8% | · | -9.7% | -7.5% | -8.3% | · | -11.6% | -9.3% | -9.2% | · | -8.6% |
Liquidez y Solvencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.3 | 10.8 | · | 7.4 | 8.3 | 8.5 | · | 8.5 | 8.5 | 9.6 | · | 5.9 | 7.1 | 6.6 | · | 5.4 | |
| Quick Ratio | 2.0 | 2.3 | · | 1.6 | 4.3 | 1.5 | · | 1.7 | 1.1 | 1.7 | · | 1.3 | 1.0 | 0.8 | · | 1.7 |
Eficiencia 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | 2.2 | · | · | · | 0.6 | · | · | · | · | · | · | · | · | · | · | · |
Valoración (TTM) 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $114M | $71M | · | $40M | $63M | $62M | · | $44M | $57M | $41M | · | $40M | $47M | $40M | · | $51M | |
| Net Income TTM | $-289M | $-294M | · | $-287M | $-247M | $-219M | · | $-206M | $-182M | $-181M | · | $-176M | $-163M | $-161M | · | $-149M | |
| Market Cap | $9.49B | $6.84B | · | $4.06B | $3.08B | $1.78B | · | $3.06B | $1.84B | $2.47B | · | $771M | $1.27B | $1.64B | · | $1.19B | |
| P/E | -35.6 | -24.4 | · | -16.0 | -13.8 | -9.4 | · | -15.8 | -10.5 | -13.6 | · | -4.5 | -7.8 | -9.9 | · | -7.7 | |
| P/S | 83.6 | 96.8 | · | 101.3 | 48.9 | 28.8 | · | 69.0 | 32.1 | 60.2 | · | 19.1 | 27.1 | 40.8 | · | 23.4 | |
| P/B | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Tangible Book | 6.3 | 4.4 | · | 4.3 | 3.2 | 2.3 | · | 3.4 | 2.7 | 3.5 | · | 1.9 | 2.9 | 3.5 | · | 2.3 | |
| P / Cash Flow | · | -77.0 | · | · | · | -22.5 | · | · | · | -62.3 | · | · | · | -37.3 | · | · | |
| P / FCF | · | -76.7 | · | · | · | -22.4 | · | · | · | -52.5 | · | · | · | -34.1 | · | · | |
| Earnings Yield | -2.8% | -4.1% | · | -6.2% | -7.3% | -10.6% | · | -6.3% | -9.5% | -7.4% | · | -22.0% | -12.8% | -10.1% | · | -13.1% |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ingresos | $39M | $47M | $79M | $47M | $73M |
| Margen Operativo % | -891.1% | -555.8% | -210.6% | -344.4% | -138.0% |
| Beneficio neto | $-311M | $-224M | $-147M | $-155M | $-100M |
| EPS Diluido | $-3.69 | $-2.98 | $-2.52 | $-2.87 | $-2.09 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio corriente | 10.5 | 7.5 | 4.7 | 5.9 | 4.9 |
| Ratio Rápido | 4.3 | 1.8 | 1.5 | 1.0 | 0.5 |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flujo de caja libre | $-234M | $-207M | $-137M | $-156M | $-131M |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 305 declarantes · $8.0B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 58 (+19 vs trimestre anterior) | 22 (-14 vs trimestre anterior) | 94 (+1 vs trimestre anterior) | 78 (+5 vs trimestre anterior) | +11.8M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | $992 725 940 | 8 657 242 | 12,48% | Acciones |
| FMR LLC | $985 896 654 | 8 597 686 | 12,40% | Acciones |
| Avoro Capital Advisors LLC | $857 129 238 | 7 474 747 | 10,78% | Acciones |
| BVF INC/IL | $444 008 203 | 3 872 052 | 5,58% | Acciones |
| WELLINGTON MANAGEMENT GROUP LLP | $376 085 378 | 3 279 719 | 4,73% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $343 114 771 | 2 992 193 | 4,31% | Acciones |
| Siren, L.L.C. | $336 651 626 | 2 935 830 | 4,23% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $336 255 785 | 2 932 378 | 4,23% | Acciones |
| Atlas Venture Life Science Advisors, LLC | $326 527 526 | 2 847 541 | 4,11% | Acciones |
| STATE STREET CORP | $313 877 705 | 2 737 226 | 3,95% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $181 558 708 | 1 582 987 | 2,28% | Acciones |
| Capital Research Global Investors | $159 262 984 | 1 388 881 | 2,00% | Acciones |
| Driehaus Capital Management LLC | $105 408 448 | 919 233 | 1,33% | Acciones |
| GOLDMAN SACHS GROUP INC | $101 597 391 | 885 998 | 1,28% | Acciones |
| Merck & Co., Inc. | $88 544 161 | 772 165 | 1,11% | Acciones |
| NORGES BANK | $86 833 399 | 757 246 | 1,09% | Acciones |
| FEDERATED HERMES, INC. | $85 933 469 | 749 398 | 1,08% | Acciones |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $84 955 104 | 740 866 | 1,07% | Acciones |
| ALLIANCEBERNSTEIN L.P. | $81 750 884 | 981 521 | 1,03% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $77 152 155 | 672 819 | 0,97% | Acciones |
| Holocene Advisors, LP | $72 996 514 | 636 579 | 0,92% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $60 744 024 | 529 729 | 0,76% | Acciones |
| EVENTIDE ASSET MANAGEMENT, LLC | $57 811 287 | 504 210 | 0,73% | Acciones |
| JENNISON ASSOCIATES LLC | $57 676 487 | 502 978 | 0,73% | Acciones |
| Woodline Partners LP | $57 434 534 | 500 868 | 0,72% | Acciones |
| Rock Springs Capital Management LP | $51 963 399 | 453 156 | 0,65% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $51 570 654 | 449 731 | 0,65% | Acciones |
| Boxer Capital Management, LLC | $49 204 897 | 429 100 | 0,62% | Acciones |
| Pictet Asset Management Holding SA | $44 984 008 | 395 540 | 0,57% | Acciones |
| BRAIDWELL LP | $43 363 951 | 378 163 | 0,55% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $43 100 784 | 375 868 | 0,54% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $42 585 457 | 371 374 | 0,54% | Acciones |
| Clearbridge Investments, LLC | $39 815 871 | 347 221 | 0,50% | Acciones |
| Octagon Capital Advisors LP | $35 547 700 | 310 000 | 0,45% | Acciones |
| Nextech Invest Ltd. | $31 981 004 | 278 896 | 0,40% | Acciones |
| Alyeska Investment Group, L.P. | $31 701 095 | 276 455 | 0,40% | Acciones |
| TD Asset Management Inc | $31 293 443 | 272 900 | 0,39% | Acciones |
| TWO SIGMA ADVISERS, LP | $29 085 378 | 373 800 | 0,37% | Acciones |
| Commodore Capital LP | $28 667 500 | 250 000 | 0,36% | Acciones |
| RTW INVESTMENTS, LP | $27 520 800 | 240 000 | 0,35% | Acciones |
| GILDER GAGNON HOWE & CO LLC | $26 265 508 | 229 053 | 0,33% | Acciones |
| Polar Capital Holdings Plc | $23 363 668 | 203 747 | 0,29% | Acciones |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $22 934 000 | 200 000 | 0,29% | Acciones |
| Candriam S.C.A. | $22 096 270 | 192 880 | 0,28% | Acciones |
| BANK OF AMERICA CORP /DE/ | $21 627 335 | 188 605 | 0,27% | Acciones |
| Eagle Health Investments LP | $19 052 191 | 166 148 | 0,24% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $17 189 950 | 149 908 | 0,22% | Acciones |
| DIADEMA PARTNERS LP | $17 166 099 | 149 700 | 0,22% | Opción de compra |
| Foresite Capital Management VI LLC | $16 779 890 | 146 332 | 0,21% | Acciones |
| WCM INVESTMENT MANAGEMENT, LLC | $16 595 869 | 151 810 | 0,21% | Acciones |
| JANE STREET GROUP, LLC | $15 732 724 | 137 200 | 0,20% | Opción de compra |
| Deer Management Co. LLC | $14 436 380 | 125 895 | 0,18% | Acciones |
| TimesSquare Capital Management, LLC | $14 063 183 | 168 846 | 0,18% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $13 794 801 | 120 300 | 0,17% | Opción de compra |
| Caption Management, LLC | $13 760 400 | 120 000 | 0,17% | Opción de venta |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $13 703 409 | 119 503 | 0,17% | Acciones |
| BOONE CAPITAL MANAGEMENT LLC | $12 977 548 | 113 173 | 0,16% | Acciones |
| ARMISTICE CAPITAL, LLC | $12 186 210 | 106 272 | 0,15% | Acciones |
| First Turn Management, LLC | $11 757 459 | 102 533 | 0,15% | Acciones |
| Ensign Peak Advisors, Inc | $11 198 672 | 97 660 | 0,14% | Acciones |
| Squarepoint Ops LLC | $11 144 663 | 97 189 | 0,14% | Acciones |
| Swiss National Bank | $10 331 767 | 90 100 | 0,13% | Acciones |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $10 262 276 | 89 494 | 0,13% | Acciones |
| Bank of New York Mellon Corp | $9 823 664 | 85 669 | 0,12% | Acciones |
| RHUMBLINE ADVISERS | $9 252 017 | 80 684 | 0,12% | Acciones |
| JPMORGAN CHASE & CO | $9 149 756 | 81 205 | 0,12% | Acciones |
| Burkehill Global Management, LP | $8 600 250 | 75 000 | 0,11% | Acciones |
| VICTORY CAPITAL MANAGEMENT INC | $8 524 567 | 74 340 | 0,11% | Acciones |
| CITIGROUP INC | $8 504 959 | 74 169 | 0,11% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $8 462 646 | 73 800 | 0,11% | Opción de venta |
| CITADEL ADVISORS LLC | $8 328 253 | 72 628 | 0,10% | Acciones |
| FIFTH THIRD BANCORP | $7 529 104 | 65 659 | 0,09% | Acciones |
| BlackRock, Inc. | $7 486 231 | 65 285 | 0,09% | Acciones |
| Yiheng Capital Management, L.P. | $7 274 665 | 63 440 | 0,09% | Acciones |
| XTX Topco Ltd | $7 052 320 | 61 501 | 0,09% | Acciones |
| FIRST TRUST ADVISORS LP | $7 037 068 | 61 368 | 0,09% | Acciones |
| Atika Capital Management LLC | $6 957 488 | 60 674 | 0,09% | Acciones |
| Nicholas Investment Partners, LP | $6 257 427 | 54 569 | 0,08% | Acciones |
| Ikarian Capital, LLC | $5 779 368 | 50 400 | 0,07% | Opción de venta |
| Patient Square Capital LP | $5 446 825 | 47 500 | 0,07% | Acciones |
| VANGUARD ASSET MANAGEMENT, Ltd | $5 250 281 | 45 786 | 0,07% | Acciones |
| PEREGRINE CAPITAL MANAGEMENT LLC | $5 237 094 | 45 671 | 0,07% | Acciones |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $4 687 728 | 56 282 | 0,06% | Acciones |
| UBS Group AG | $4 678 880 | 40 803 | 0,06% | Acciones |
| AXA Investment Managers S.A. | $4 558 224 | 80 534 | 0,06% | Acciones |
| VOYA INVESTMENT MANAGEMENT LLC | $4 451 260 | 38 818 | 0,06% | Acciones |
| MARSHALL WACE, LLP | $4 273 177 | 37 265 | 0,05% | Acciones |
| STATE OF WISCONSIN INVESTMENT BOARD | $4 223 640 | 36 833 | 0,05% | Acciones |
| MetLife Investment Management, LLC | $4 184 767 | 36 494 | 0,05% | Acciones |
| Rafferty Asset Management, LLC | $4 046 360 | 35 287 | 0,05% | Acciones |
| Odyssean, LLC | $3 954 395 | 34 485 | 0,05% | Acciones |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $3 851 880 | 33 591 | 0,05% | Acciones |
| CITADEL ADVISORS LLC | $3 841 445 | 33 500 | 0,05% | Opción de venta |
| Aquilo Capital Management, LLC | $3 791 320 | 138 521 | 0,05% | Acciones |
| Nan Fung Group Holdings Ltd | $3 540 436 | 30 875 | 0,04% | Acciones |
| Moody Aldrich Partners LLC | $3 440 788 | 30 006 | 0,04% | Acciones |
| SEVEN GRAND MANAGERS, LLC | $3 440 100 | 30 000 | 0,04% | Acciones |
| 683 Capital Management, LLC | $3 440 100 | 30 000 | 0,04% | Opción de venta |
| CITADEL ADVISORS LLC | $3 428 633 | 29 900 | 0,04% | Opción de compra |
| NEW YORK STATE COMMON RETIREMENT FUND | $3 300 203 | 28 780 | 0,04% | Acciones |
Informantes de la empresa 24 insiders · 10 directivos · 13 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Nello Mainolfi | Chief Executive Officer | 7 de julio de 2026 M | 666 568 | 0 | 21 | $-34 875 625 |
| Bruce N. Jacobs | Chief Financial Officer | 30 de junio de 2026 M | 244 883 | 0 | 16 | $-13 917 105 |
| Jeremy G Chadwick | Chief Operating Officer | 27 de mayo de 2026 S | 44 018 | 0 | 29 | $-15 599 618 |
| Terence Rooney | Chief Medical Officer | 27 de julio de 2026 A | 38 000 | 0 | 0 | $0 |
| Noah Goodman | Chief Business Officer | 1 de julio de 2026 S | 47 179 | 0 | 9 | $-2 223 845 |
| Jared Gollob | Chief Medical Officer | 2 de marzo de 2026 A | 117 134 | 0 | 18 | $-9 134 491 |
| Brian Adams | Chief Legal Officer | 2 de marzo de 2026 A | 56 625 | 0 | 0 | $0 |
| Ellen Chiniara | Chief Legal Officer | 3 de marzo de 2025 A | 80 085 | 0 | 0 | $0 |
| Elaine Caughey | Chief Business Officer | 1 de marzo de 2023 A | 18 986 | 0 | 0 | $0 |
| Richard Chesworth | Chief Scientific Officer | 27 de agosto de 2021 M | 0 | 0 | 0 | $0 |
| Bruce Booth | Consejero | 29 de junio de 2026 S | 462 856 | 0 | 137 | $-195 559 433 |
| Hrustanovic Gorjan | Consejero | 24 de junio de 2026 A | — | 0 | 0 | $0 |
| Elena Ridloff | Consejero | 24 de junio de 2026 A | 0 | 0 | 4 | $-1 285 644 |
| Pamela Esposito | Consejero | 24 de junio de 2026 A | 1 000 | 0 | 12 | $-3 054 174 |
| Jeffrey W. Albers | Consejero | 24 de junio de 2026 A | 0 | 0 | 3 | $-744 757 |
| Victor Sandor | Consejero | 24 de junio de 2026 A | — | 0 | 0 | $0 |
| John Maraganore | Consejero | 24 de junio de 2026 A | — | 0 | 0 | $0 |
| Leigh Morgan | Consejero | 18 de junio de 2024 A | — | 0 | 0 | $0 |
| Joanna Horobin | Consejero | 7 de junio de 2024 M | 0 | 0 | 0 | $0 |
| Donald William Nicholson | Consejero | 15 de junio de 2022 A | — | 0 | 0 | $0 |
| Steven Edward Hall | Consejero | 25 de agosto de 2020 C | 2 192 249 | 0 | 0 | $0 |
| Andrew Hedin | Consejero | 20 de agosto de 2020 A | — | 0 | 0 | $0 |
| Atlas Venture Fund X, L.P. | Propietario del 10% | 18 de mayo de 2021 J | 5 763 012 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Propietario del 10% | 25 de agosto de 2020 C | 959 211 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P, BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II LP, BVF II GP LLC, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., BVF GP HOLDINGS LLC, BVF PARTNERS L P/IL, BVF INC/IL, LAMPERT MARK N, Hrustanovic Gorjan ×2 presentaciones | 26 de junio de 2026 | 6,30% | Enmienda | — | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×4 presentaciones | 11 de diciembre de 2025 | 10,90% | Enmienda | Estructura de capital | SEC |
| BIOTECHNOLOGY VALUE FUND, L.P., BVF I GP LLC, BIOTECHNOLOGY VALUE FUND II, L.P., BVF II GP LLC, BIOTECHNOLOGY VALUE TRADING FUND OS, L.P., BVF PARTNERS OS LTD., BVF GP HOLDINGS LLC, BVF PARTNERS L.P., BVF INC., MARK N. LAMPERT, GORJAN HRUSTANOVIC ×5 presentaciones | 9 de enero de 2024 | — | Presentación inicial | — | SEC |
| Vertex Pharmaceuticals Incorporated ×2 presentaciones | 5 de junio de 2023 | — | Presentación inicial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Propiedad de ETFs Mantenido por 64 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 4,23% | 84 154 NS | 31 de mayo de 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,99% | 10 000 NS | 31 de mayo de 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,76% | 34 157 NS | 30 de abril de 2026 | N-PORT |
| GURU · Global X Funds | 1,04% | 7 506 NS | 30 de abril de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,93% | 59 553 NS | 30 de abril de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,67% | 3 077 NS | 30 de abril de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,60% | 4 477 SH | 8 de agosto de 2026 | Diario |
| IBB · iShares Trust | 0,58% | 522 187 SH | 8 de agosto de 2026 | Diario |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,50% | 3 204 NS | 31 de mayo de 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,39% | 24 697 NS | 30 de abril de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,35% | 55 351 SH | 8 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,34% | 469 031 SH | 8 de agosto de 2026 | Diario |
| BIB · ProShares Trust | 0,33% | 3 017 NS | 31 de mayo de 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,33% | 1 305 NS | 31 de mayo de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,31% | 979 NS | 30 de abril de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,23% | 20 749 NS | 30 de abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,22% | 360 394 SH | 8 de agosto de 2026 | Diario |
| VBK · VANGUARD INDEX FUNDS | 0,21% | 871 540 SH | 8 de agosto de 2026 | Diario |
| IWM · iShares Trust | 0,21% | 1 586 740 SH | 8 de agosto de 2026 | Diario |
| BKSE · BNY Mellon ETF Trust | 0,19% | 1 938 NS | 30 de abril de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 32 324 SH | 8 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,14% | 24 820 NS | 30 de abril de 2026 | N-PORT |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,13% | 21 796 NS | 30 de abril de 2026 | N-PORT |
| ITWO · ProShares Trust | 0,12% | 2 699 NS | 31 de mayo de 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,11% | 6 792 NS | 30 de abril de 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,11% | 294 706 NS | 31 de mayo de 2026 | N-PORT |
| ISCV · iShares Trust | 0,09% | 5 956 SH | 8 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,09% | 1 509 269 SH | 8 de agosto de 2026 | Diario |
| ISCG · iShares Trust | 0,09% | 8 334 SH | 8 de agosto de 2026 | Diario |
| ISCB · iShares Trust | 0,09% | 2 398 SH | 8 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,08% | 22 424 SH | 8 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,08% | 143 695 NS | 30 de abril de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,08% | 726 357 SH | 8 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,08% | 9 461 SH | 8 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,08% | 134 854 SH | 8 de agosto de 2026 | Diario |
| ESML · iShares Trust | 0,08% | 21 257 SH | 8 de agosto de 2026 | Diario |
| IWN · iShares Trust | 0,07% | 101 814 SH | 8 de agosto de 2026 | Diario |
| UWM · ProShares Trust | 0,07% | 2 111 NS | 31 de mayo de 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,06% | 21 910 NS | 30 de abril de 2026 | N-PORT |
| URTY · ProShares Trust | 0,05% | 2 136 NS | 31 de mayo de 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,05% | 61 NS | 31 de mayo de 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 2 882 SH | 8 de agosto de 2026 | Diario |
| GSSC · Goldman Sachs ETF Trust | 0,04% | 5 327 NS | 31 de mayo de 2026 | N-PORT |
| AVMC · AMERICAN CENTURY ETF TRUST | 0,03% | 1 604 NS | 31 de mayo de 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,02% | 2 239 NS | 31 de mayo de 2026 | N-PORT |
| HDG · ProShares Trust | 0,02% | 54 NS | 31 de mayo de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,02% | 93 115 NS | 30 de abril de 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 19 514 NS | 31 de mayo de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 675 NS | 30 de abril de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 2 916 NS | 30 de abril de 2026 | N-PORT |